Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation Expense

Stock-based compensation expense included in cost of goods sold and operating expenses during the three and six months endedJune 30, 2017 and 2016, was as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2017		2016		2017		2016
Cost of goods sold	$	304	$	259	$	473	$	532
Operating expenses:
Research and development	323		434		583		797
Clinical and regulatory affairs	160		593		420		493
Marketing and sales	1,283		1,261		2,341		2,391
General and administrative	1,164		1,339		2,371		2,555
Total operating expenses	$	2,930	$	3,627	$	5,715	$	6,236
Total	$	3,234	$	3,886	$	6,188	$	6,768